Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells  by Dathe, Margitta & Wieprecht, Torsten
Review
Structural features of helical antimicrobial peptides: their potential to
modulate activity on model membranes and biological cells
Margitta Dathe a;*, Torsten Wieprecht b
a Research Institute of Molecular Pharmacology, Alfred-Kowalke-Strasse 4, D-10315 Berlin, Germany
b Biocenter of the University of Basel, Department of Biophysical Chemistry, Klingelbergstrasse 70, CH-4056 Basel, Switzerland
Accepted 5 October 1999
Abstract
Antibacterial, membrane-lytic peptides belong to the innate immune system and host defense mechanism of a multitude of
animals and plants. The largest group of peptide antibiotics comprises peptides which fold into an amphipathic K-helical
conformation when interacting with the target. The activity of these peptides is thought to be determined by global structural
parameters rather than by the specific amino acid sequence. This review is concerned with the influence of structural
parameters, such as peptide helicity, hydrophobicity, hydrophobic moment, peptide charge and the size of the hydrophobic/
hydrophilic domain, on membrane activity and selectivity. The potential of these parameters to increase the antibacterial
activity and to improve the prokaryotic selectivity of natural and model peptides is assessed. Furthermore, biophysical
studies are summarized which elucidated the molecular basis for activity and selectivity modulations on the level of model
membranes. Finally, the knowledge about the role of peptide structural parameters is applied to understand the different
activity spectra of natural membrane-lytic peptides. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Peptides with cell-lytic activity are ubiquitous in
nature, constituting a defense system against invad-
ing microorganisms in many organisms (for reviews,
see [1^3]). The peptides can be classi¢ed into several
groups on the basis of their origin, activity spectrum
or structure (for a review, see [4]). Helical peptides,
typi¢ed by melittin from bees, magainins from frogs
and cecropin P1 from pig, are the most widely dis-
tributed and have the broadest spectrum of activity
(Table 1, Fig. 1). In this review we will focus on
linear peptides which assume an K-helical conforma-
tion when interacting with the target.
The challenge of bacterial resistance to conven-
tional antibiotics [5], and the remarkable antibacte-
rial selectivity of many peptides and their unique
mode of action, have made such peptides promising
candidates for the development of a new class of
antibiotics [6,7]. Considerable e¡ort has been made
to elucidate the mode of action and to understand
the structural basis of membrane selectivity with the
goal of optimizing peptide antimicrobial activity (for
reviews, see [8^10]).
The available evidence suggests that the peptides
exert their cell-lytic e¡ect by a two-step mechanism
consisting of (i) binding to the cell surface and (ii)
membrane permeabilization. Largely unstructured in
solution, linear peptides fold into an amphipathic
helix upon binding to the target membrane, insert
into the membrane and disturb the barrier function
in di¡erent ways. Membrane permeabilization leads
to a breakdown of the transmembranal potential and
of ion gradients and causes leakage of cell contents,
resulting ¢nally in cell death. In addition to a dis-
turbance of the membrane function by formation of
ion channels, two other mechanisms of membrane
permeabilization are at present under discussion. A
global disturbance of the lipid arrangement resulting
from a very dense peptide accumulation has been
proposed for a variety of peptides and was desig-
nated the ‘carpet mechanism’ (for a review, see
[11]). This mode of action is supported by the facts
that peptides mainly adopt a parallel orientation to
the lipid bilayer and permeabilize it even in the ab-
sence of a transmembrane potential. The second
mechanism is pore formation. Local thinning of the
membrane at the site of peptide binding [12] may
favor the formation of transitory pores connecting
the inner and outer lea£ets by a complex peptide
lipid arrangement as recently suggested for magainin
and melittin (for a review, see [9]).
Distinct di¡erences in the membrane properties of
prokaryotic and eukaryotic cells appear to regulate
activity and speci¢city. Antimicrobial peptides have
been postulated to overcome the high negative
charge of the outer wall of Gram-negative bacteria
by inducing transient lesions large enough to permit
the passage of peptides (self-promoted uptake) [6].
Negatively charged lipids favor peptide binding and
an inside negative transmembrane potential supports
penetration of the inner membrane. The cytoplasmic
membrane of Gram-positive bacteria is directly ex-
posed to the lytic peptides and its negative charge
facilitates interaction with cationic compounds.
For a peptide to act as part of the host defence
system or to be of pharmaceutical interest, high anti-
microbial activity must be combined by a low activ-
C
Fig. 1. Helical wheel projections and schematic drawings of the amphipathic helices of melittin, magainin 2 amide, cecropin P1 and a
KLAL model peptide illustrating the di¡erent structural features. The one letter code for amino acids is used. Hydrophobic residues
are shown in white, polar residues in gray and cationic residues in black circles. N is the number of residues. The total charge Q was
calculated under the assumption that K, R and the N-terminal NH2 are positively charged and E and the C-terminal COOH bear a
negative charge. H is the mean residue hydrophobicity, calculated on the basis of the Eisenberg [45] consensus scale of hydrophobic-
ity. The angle subtended by the charged residues on the helix surface is denoted by x. Hh is the hydrophobicity of the non-charged
domain (360‡3x). W is the hydrophobic moment calculated as the vector sum of the hydrophobicities of all residues, assuming an
ideal K-helix. H and W of melittin were calculated for the K-helical region only (residues 1^21 [92]).
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Table 1
Origin and properties of representative cytolytic peptides





Bacterium Staphylococcus aureus N-Hemolysin 27, linear K-Helical ++ 3 3 [88]
0
Insects
Bee venom Melittin 26, linear K-Helical ++ ++ ++ [89]
+6
Amphibians
Frog skin Xenopus laevis Magainin 2 23, linear K-Helical 3 ++ ++ [90]
+4
Mammals
Porcine small intestine Cecropin P1 31, linear K-Helical 3 + ++ [91]
+5
++, + and 3 denote high, low and practically no biological activity, respectively; RBC, red blood cells.
Table 2
E¡ect of parameter modi¢cation of magainin 2 amide and of the amphipathic KLAL model peptide on a⁄nity, permeabilizing e⁄-
ciency and activity on neutral (erythrocyte membrane) phosphatidylcholine (POPC) and negatively charged (bacterial membrane)
POPC/POPG bilayers and the hemolytic and antimicrobial activity
Small and large up and down arrows and W symbolize small/large increases, reductions and almost no change of the corresponding
feature, respectively. MIC, minimal inhibitory concentration of bacterial growth; RBC, red blood cells ; EC50, concentration of half-
maximal hemolysis ; n.d., not determined; 1determined only for KLAL; K, helicity; H, hydrophobicity; W, hydrophobic moment; x,
angle subtended by cationic residues; 8= (360‡3x), angle of the hydrophobic domain. For interpretation of the table it is to consider
that the peptide a⁄nity is by orders of magnitude higher for negatively charged lipid bilayers compared to neutral ones while the per-
meabilizing e⁄ciency is much higher on neutral than on negatively charged membranes.
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ity against red blood cells. The membrane of red
blood cells, typically for eukaryotic cells, is com-
posed exclusively of neutral phospholipids and has
a high cholesterol content [13].
Di¡erent strategies have been developed to gener-
ate highly active antimicrobial peptides which pos-
sess a low hemolytic activity. One approach has in-
volved the analysis of sequences of naturally
occurring antimicrobial and hemolytic peptides in
order to extract sequence regions that may contrib-
ute to activity, and thereafter to synthesize peptide
analogues according to these patterns [14^16]. The
second method uses combinational libraries and has
been successfully applied to the development of hel-
ical antimicrobial peptides [17]. The third method is
based on systematic studies of the role of structural
properties of helical peptides in membrane interac-
tion (for a review, see [10]). A diversity of studies
have described the in£uence of peptide charge, hel-
icity, intrinsic hydrophobicity, hydrophobic moment
and the size of the polar/hydrophobic domain (cf.
Table 2) on the permeabilizing e¡ect on lipid bilayers
and on antimicrobial and hemolytic activity. Most
studies, however, have not considered that sequence
modi¢cations usually result in complex changes of
more than one structural parameter, making it di⁄-
cult to trace activity di¡erences back to a speci¢c
structural motif.
This review addresses the question of the molecu-
lar basis of membrane activity and selectivity.
A variety of membrane model systems and a rich
arsenal of methods for physico-chemical studies of
peptide-membrane interaction (for reviews, see
[8,9]) provide the basis for the interpretation of bio-
logical results. Based on our own systematic studies,
we focus on advances in understanding the role of
helicity, hydrophobicity, hydrophobic moment, the
size of the polar/apolar helix domain and peptide
charge for both binding and permeabilizing e⁄-
ciency. The correlation of the e¡ects on model mem-
branes with activity against bacteria and red blood
cells shows that these parameters may provide a
powerful basis for the optimization of peptide struc-
ture with respect to antimicrobial activity. Further-
more, the data suggest that ion channels, pores and
global membrane rupture do not represent three
completely di¡erent modes of action, but rather
that there is a continuous graduation between
them. The predominance of a speci¢c membrane-per-
meabilizing mechanism is determined by the inter-
play of structural motifs of the peptides and by their
target-dependent in£uence on the binding and per-
meabilization steps.
2. Structural parameters capable of modulating
activity and selectivity
2.1. Helicity
The amphipathic helix is a membrane-binding mo-
tif in many proteins and peptides formed by linear
amino acid chains with a periodicity of polar and
apolar residues of about three to four (Fig. 1) [18].
This structure, with the polar side chains aligned
along one side and the hydrophobic residues along
the opposite side of the helical coat, allows an opti-
mal interaction of the peptides with the amphiphilic
structure of the biological membrane.
It is well known that certain amino acids favor the
adoption of the helical structure while others desta-
bilize it [19]. Thus, early studies directed towards
enhancing membrane activity and improving the
antimicrobial e¡ect were based on appropriate amino
acid substitutions to increase peptide helicity. Such
an increased helicity, attained by either deleting gly-
cine or substituting it with leucine in the N-terminal
helix of melittin, correlated well with an enhanced
hemolytic and antibacterial activity of the peptide
[20,21]. However, substitution of lysine at position
7 by glycine, reducing the helix propensity, had little
in£uence on the antimicrobial and hemolytic activity
[22]. Substitution of glycine residues by helix-pro-
moting alanine drastically improved the antibacterial
and hemolytic activity of magainin peptides [23,24].
Other magainin 2-derived peptides, which were de-
signed to have more amphipathic K-helix than mag-
ainin 2, showed especially improved antibacterial ac-
tivity [25]. Comparable results were reported for
substitution of helix-breaking proline residues. The
1^18 stretch of the 33-residue shark repellent neuro-
toxin pardaxin is highly active against Escherichia
coli, but does not show cytolytic activity. Substitu-
tion of proline 7 by alanine distinctly enhanced hel-
icity and induced hemolytic activity [26].
Inversely, substitutions which prevent folding of
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melittin into a helical conformation resulted in a loss
of both hemolytic and antimicrobial activity [27].
Furthermore, incorporation of proline in the N-ter-
minal helix of insect cecropin A [28] and cecropin P1
[29] reduced activity against di¡erent bacterial
strains, which correlated well with decreased helicity.
Although these ¢ndings unquestionably demon-
strate the general importance of the amphipathic he-
lix for the biological e¡ect, a quantitative correlation
of helicity with membrane activity was seldom dem-
onstrated. One reason is that in addition to modi¢-
cation of peptide helicity, amino acid substitutions
involving changes in the character of the side chain
(charge, hydrophobicity, surface area) a¡ect other
peptide properties such as the hydrophobic moment,
the hydrophobicity, and the size of the polar/hydro-
phobic domain, as well as charge and charge distri-
bution.
More detailed information concerning the role of
helicity in the antimicrobial and hemolytic e¡ects
came from studies of peptides modi¢ed by replace-
ment of L-amino acids by their corresponding enan-
tiomers. D-Amino acid substitutions locally disturb
helix formation of linear peptides while retaining
the sequence, intrinsic hydrophobicity and charge.
Pouny and Shai [30] reported that helix disturbance
by D-amino acid substitution in pardaxin distinctly
reduced the hemolytic activity of the peptide.
Although no correlation between helicity and the ef-
¢ciency to induce dye release from lipid vesicles was
found, these early studies showed that peptide helic-
ity might be more important for activity on neutral
than on negatively charged lipid bilayer membranes.
Replacement of two adjacent amino acid residues
by their D-isomers has been found to induce a more
pronounced local disturbance of helix conformation
than does single amino acid substitution [31]. A sys-
tematic exchange of two neighboring residues in
magainin by their D-enantiomers (double D-amino
acid replacement set) resulted in decreased helicity
in the membrane-bound state and distinctly reduced
its permeabilizing activity against neutral and mod-
erately negatively charged lipid vesicles. In contrast,
almost no di¡erences were found in the peptide con-
centrations inducing permeability in highly nega-
tively charged phosphatidylglycerol membranes [32].
Investigations with a cationic amphipathic KLAL
model peptide (Fig. 1) con¢rmed that the amphi-
pathic helix is essential for the action on neutral lipid
membranes but appears less important for the per-
meabilization of negatively charged bilayers [33].
Studies with double D-amino acid substitution sets
provided a deeper insight into the relevance of hel-
icity to peptide binding and their ability to permea-
bilize lipid membranes. The high a⁄nity of the cat-
ionic peptides to negatively charged membranes
suggests that the accumulation is driven by electro-
static forces. However, the high a⁄nity is o¡set by a
Fig. 2. Permeabilizing activity of the amphipathic helical model
peptide KLAL and of a non-helical analogue produced by sub-
stitution of residues 9 and 10 by the corresponding D-amino
acids on negative charged phosphatidylglycerol (POPG), phos-
phatidylcholine (POPC) and mixed POPC/POPG (3/1) vesicles
(lipid concentration, 12 WM). EC50 is the concentration required
to induce F = 50% dye release. The permeabilizing e⁄ciency of
bilayer bound peptides is represented by rF50% denoting the
molar ratio of bound peptide per lipid inducing 50% dye re-
lease. There is no di¡erence in the activity of the two structur-
ally di¡erent peptides on highly negatively charged vesicles.
With reduction of membrane charge the permeabilizing e⁄-
ciency of the helical peptide increases by a factor of 10 result-
ing in enhanced activity despite low binding. The ability of the
non-helical analogue to induce dye release from neutral vesicles
is much reduced. This is caused by a distinctly reduced permea-
bilizing e⁄ciency in addition to a decreased a⁄nity [33].
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comparably low permeabilizing e⁄ciency as docu-
mented for the KLAL model, in which a high num-
ber of bound molecules per lipid appears necessary
to induce dye release from lipid vesicles (Fig. 2). An
identical membrane a⁄nity and permeabilizing e⁄-
ciency, despite distinct structural di¡erences, suggest
that high binding is su⁄cient to destabilize highly
negatively charged lipid membranes [33].
With reduction of electrostatic interactions in the
case of a reduced lipid bilayer charge, the peptide
a⁄nity decreases [32,33]. Concomitantly, hydropho-
bic interactions become more relevant. This is con-
¢rmed by the observed reduction of the bilayer a⁄n-
ity of analogues with a disturbed amphipathic helix.
On the progressive reduction of membrane lipid neg-
ative charge, the ability of KLAL to disturb the neu-
tral lipid bilayer distinctly increases (Fig. 2). The
high permeabilizing e⁄ciency decreases, however, as
soon as the amphipathic helix is disturbed. In con-
clusion, the high activity of peptides against neutral
membranes is related to a well established hydropho-
bic peptide domain which provides the high mem-
brane permeabilizing e⁄ciency.
A relationship between helicity and activity is also
found on the cell membrane level. KLAL analogues
with low helicity, low a⁄nity, and low permeabiliz-
ing e⁄ciency on neutral membranes (charge corre-
sponds to erythrocyte membrane) are unable to lyse
red blood cells. On bacterial membranes, however,
the relation between helicity and activity is more
complex. E¡ects determined by charge and hydro-
phobic peptide-membrane interactions superimpose.
While the model peptides displayed only moderate
changes in antimicrobial activity with reduced helic-
ity, the antimicrobial activity of magainin double D-
isomers practically disappeared [33].
Comparable results have been reported for diaster-
eomers of melittin [34] and pardaxin [35]. The D-ami-
no acid-containing peptides lost their helix structure,
which abrogated their hemolytic activity but did not
diminish their antibacterial activity. The antimicro-
bial activity correlated with peptide binding and the
membrane-destabilizing e¡ect on liposomes. Only he-
molytic peptides bind to and destabilize zwitterionic
phospholipid membranes, while the diastereomers in-
teract only with negatively charged phospholipids.
Studies of D-amino acid-containing KL model pep-
tides [36] complete the picture. The non-helical pep-
tides are very weakly or not active against neutral
lipids, but the permeability enhancing e¡ect of the
stereoisomers on negatively charged phosphatidyl-
ethanolamine/phosphatidylglycerol liposomes is high
and little di¡erentiated and correlates with the anti-
bacterial activity against E. coli.
Helix-inducing organic solvents such as TFE are
frequently referred to as ‘membrane mimicking’.
However, structure-inducing driving forces in iso-
tropic solvents and on the non-isotropic membrane
interface are generally di¡erent. Alcohols weaken
non-local hydrophobic interactions and favor local
polar interactions, such as the formation of intramo-
lecular hydrogen bonds [37]. On lipid model mem-
branes the hydrophobic interactions between peptide
side chains and lipid acyl chains appear to be the
primary forces driving secondary structure formation
[38]. Wimley and White [39] have shown that the
very unfavorable free energy contribution of parti-
tioning of the polar peptide bonds into the lipid bi-
layer hampers peptide insertion. They proposed that
intramolecular NH-CO hydrogen bonding reduces
the energy costs of partitioning and thereby pro-
motes helix formation (for a review, see [40]). Studies
with magainin peptides show that helicity is inde-
pendent of the membrane charge, indicating that
electrostatic interactions driving the accumulation
of the cationic peptide at negatively charged mem-
branes have little in£uence on the peptide conforma-
tion [32].
As a result of di¡erent driving forces, the second-
ary structure of lytic peptides may be quite di¡erent
in structure-inducing organic solution or when
bound to lipid membranes. This is convincingly dem-
onstrated by conformational studies with pardaxin
peptides. These peptides were shown to adopt a hel-
ical or L-sheet structure depending on whether lipid
vesicles or di¡erent concentrations of TFE and so-
dium dodecyl sulfate (SDS) were used in the experi-
ments [26,41]. An amphipathic model peptide was
found to be helical in the presence of organic sol-
vents but L-structured in the presence of SDS or
upon binding to the interface of a C18-acyl chain-
coated plate [42]. Considerable di¡erences in struc-
ture have also been reported for cecropin-magainin
hybrids, displaying a helical content of 56% in TFE
but only 17% in the presence of negatively charged
SDS micelles [43]. The helicity of magainin 2 amide
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was found to be about 55% in TFE/bu¡er and 76%
in the lipid membrane-bound state [32].
The problem of determining the structure of lipid-
bound peptides arises mainly from limitation of the
available methods. The method of choice is two-
dimensional 1H-NMR spectroscopy; the application
of this technique to the study of lipid vesicle-associ-
ated peptides has, however, proved problematical be-
cause of slow molecular reorientation rates involved.
Other spectroscopic methods such as circular dichro-
ism (CD), Raman and Fourier transformed infrared
spectroscopy (FTIR) can be used to obtain informa-
tion about peptide conformation in the model mem-
brane-bound state. The disadvantage of these tech-
niques is that they provide an overall picture of the
conformation but do not generally allow localization
of structural motifs within the peptide sequence. An
approach to obtain such information using CD spec-
troscopy has recently been developed by combining
this method with systematic double D-amino acid
substitution [32,33]. Studies with a magainin double
D-replacement set [32] con¢rmed the results obtained
by solid state NMR measurements of selectively 15N
labeled magainin analogues [44], indicating that the
peptide is completely helical in the lipid-bound state.
The high sensitivity of CD spectroscopy additionally
revealed that the magainin helix is rather £exible at
the N-terminus and more stable in the region ranging
from residue 9 to 20. The same approach led to the
result that a potentially amphipathic KLAL model
peptide in a membrane environment is characterized
by a central helix and £exible N- and C-termini [33].
Finally, it should be emphasized again that valid
structure-activity correlation studies require extensive
knowledge concerning the conformation of the lipid
membrane-bound peptide.
2.2. Hydrophobic moment
The hydrophobic moment is a quantitative meas-
ure of peptide amphipathicity. It is de¢ned as the
vector sum of the hydrophobicities of the individual
amino acids (Fig. 1) [45]. Originally, this concept was
developed to study protein folding [46], but the more
general de¢nitions were subsequently found to be
applicable to membrane-related protein and peptide
structures. The hydrophobic moment plot, i.e. the
dependence of the hydrophobic moment per residue
on the mean residue hydrophobicity, may be used to
predict the membrane activity of peptide helices. Ac-
cording to this plot, membrane lytic peptides tend to
cluster in a region of high hydrophobic moment and
moderate hydrophobicity. However, a complete cor-
relation of the hydrophobic moment and activity is
rendered more di⁄cult because of two factors.
(i) In many peptides, such as melittin (Fig. 1), the
hydrophobic and hydrophilic residues are not regu-
larly distributed within the chain. As a consequence,
there are regions characterized by higher and lower
hydrophobic moments. An extension of the hydro-
phobic moment concept is the hydrophobicity poten-
tial, depicting both the hydrophobic gradient along a
peptide sequence and the hydrophobic contours
around a helix [47]. However, most authors prefer
to use the traditional hydrophobic moment to assess
amphipathicity.
(ii) The hydrophobic moment is calculated on the
basis of an ideal helix but the helicity of membrane-
bound peptides is often considerably lower than
100%. As shown for magainin [32], chain regions
with highest amphipathicity and the most stable helix
region provide the greatest contribution to peptide
activity. However, the problem of simultaneous con-
sideration of changes in amphipathicity as result of
modi¢cation of both the secondary structure and the
peptide sequence, has not been satisfactory solved.
Matsuzaki et al. [48] did not ¢nd a correlation be-
tween the hydrophobic moment and the lytic activity
of di¡erent peptides. This was not surprising consid-
ering the large di¡erences in hydrophobicity, overall
charge, and secondary structure of peptides such as
magainin, alamethicin, tachyplesin and gramicidin S.
In contrast, the gradual reduction of the hydropho-
bic moment of melittin by substitution of lysine in
the hydrophobic N-terminal helix led to a loss of
antimicrobial and hemolytic activity [27]. Recent
studies with a highly polar C-terminal melittin frag-
ment showed that minor rearrangement in the se-
quence, correlated with an increase of W, resulted in
a considerably increased antimicrobial activity [49].
An attempt to quantify the dependence of the anti-
microbial activity of magainin 2 and 12 derived ana-
logues led to the conclusion that the mean hydro-
phobic moment is a more important factor
governing antimicrobial activity than are hydropho-
bicity or helix content [50].
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The relation between hydrophobic moment and
activity has also been studied by the use of cationic
model peptides composed of only a few di¡erent
amino acids. Blondelle et al. [51] reported that intro-
duction of lysine into the hydrophobic region of a
model peptide enhanced the antimicrobial activity,
although the substitution also disturbed the hydro-
phobic domain and decreased the hydrophobic mo-
ment, as re£ected by a lower retention time in re-
versed phase HPLC. Introduction of hydrophobic
residues in the hydrophilic helix face resulted in com-
pounds which displayed also higher antibacterial ac-
tivity than the parent sequence and were additionally
considerably hemolytic. Since the bioactivity of each
of the two series of peptides was almost independent
of the site of substitutions, it is obvious that param-
eters other than the hydrophobic moment predomi-
nate in this instance.
In addition to our e¡orts to understand the gen-
eral role of the amphipathic helix for the membrane
lytic e¡ect, we investigated in detail the in£uence of
the hydrophobic moment on antimicrobial and he-
molytic activity and analyzed the biophysical princi-
ples involved in the modulation of membrane activity
[52^54]. To overcome the problem of simultaneous
changes of other parameters, we employed an ap-
proach of minimal sequence modi¢cation. According
to this approach, the hydrophobic moment was
modulated by a few conservative amino acid substi-
tutions, while the hydrophobicity, the peptide charge,
the chain length and the angles subtended by the
hydrophilic and hydrophobic helix faces were largely
kept constant. Studies with analogues of the antibac-
terial magainin 2 amide indicated that slight en-
hancement of the hydrophobic moment by a few
conservative amino acid substitutions substantially
increased the antimicrobial activity but also induced
hemolytic activity. The activity increase on moder-
ately negatively charged lipid bilayers paralleling bio-
activity was mainly caused by enhanced binding due
to strengthened hydrophobic interactions (Fig. 3).
The permeabilizing e⁄ciency of the membrane-
bound peptides was barely a¡ected [52]. Additional
studies with KLAL model peptides revealed that the
hydrophobic moment plays a minor role in the per-
meabilization of highly charged lipid membranes but
substantially in£uences their e¡ect on neutral lipid
membranes. This observation con¢rms that changes
of the hydrophobic moment predominately in£uence
hydrophobic peptide-lipid bilayer interactions [54].
Interestingly, the activity modulating e¡ect of the
hydrophobic moment decreases for peptides of very
low as well as high hydrophobicity [53]. Obviously,
there is a limited hydrophobicity range within which
the hydrophobic moment is a strong modulator of
membrane disrupting activity.
In conclusion, modi¢cations of the hydrophobic
moment are an applicable tool to regulate the bio-
activity of peptides. However, the opportunity to de-
sign peptides with substantially increased antimicro-
bial activity, while retaining selectivity, remains
limited.
2.3. Hydrophobicity
The peptide hydrophobicity re£ects the intrinsic
Fig. 3. In£uence of structural parameters (W, hydrophobic mo-
ment; H, hydrophobicity; x, angle of the polar helix domain)
of magainin peptides on the lipid a⁄nity (POPC/POPG 3:1
vesicles). The peptides shown are: b, M2a (magainin 2 amide)
[60] ; 8, 140‡ M2a (enhanced x) [71]; R, I6A8L15I17 M2a (en-
hanced H) [60] ; F, I6V9W12T15I17 M2a (enhanced W) [52]. The
permeabilization range indicates the molar ratio of bound pep-
tide per lipid, where the POPC/POPG (3:1) membrane becomes
permeable.
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capability of a peptide to move from an aqueous into
a hydrophobic phase. Hydrophobic interactions, in
addition to other forces such as electrostatic interac-
tions, conformational transitions and van der Waals
interactions, play a major role in the partitioning of
antibacterial peptides into the lipid bilayer of biolog-
ical membranes. Peptide hydrophobicity is hence ex-
pected to be a strong modulator of membrane activ-
ity. With respect to hydrophobicity, two general
requirements have to be ful¢lled for a membrane-
lytic peptide to be part of the host defense system:
(i) the peptide has to be su⁄ciently soluble in water
to allow storage in high concentration and to enable
rapid transport to the microbial target (low hydro-
phobicity required) and (ii) it must be able, at the
same time, to interact with the hydrophobic region of
the bilayer in order to disturb the bilayer structure
and to enhance the membrane permeability (high
hydrophobicity required). However, too high a hy-
drophobicity would result in self-association or even
precipitation of the peptide in water and would thus
prevent its transport to the microbial target. On the
other hand, a peptide with a very low hydrophobicity
has an insu⁄cient lipid a⁄nity.
Several studies have addressed the question of the
relation between hydrophobicity and antibacterial
activity. Juvvadi [55] reported that the antibacterial
activity of a cecropin A-melittin hybrid peptide could
well be modulated by the hydrophobicity of the res-
idue in position 8. Likewise, hydrophobicity was, be-
side amphipathicity, the most important factor deter-
mining the antibacterial e¡ect of a set of analogues
of the antimicrobial peptide CAMEL0 [56].
However, hydrophobicity was much less important
than the hydrophobic moment for the antibacterial
activity of peptides derived from the antisense se-
quence of magainin 2 [50]. Several studies using mod-
el peptides even indicated that no strong correlation
exists between antibacterial e¡ect and hydrophobic-
ity [51,57,58].
A more direct relation seems to exist between
hemolytic activity and hydrophobicity. For model
peptides of di¡erent chain lengths and peptide hydro-
phobicity, a clear correlation between hydrophobic-
ity and the ability to induce hemolysis has been ob-
served [58]. Blondelle and Houghten [51] reported
that the decrease of hydrophobicity resulting from
substitution of lysine for leucine in the hydrophobic
region of an amphipathic model peptide considerably
reduced its hemolytic activity. On the other hand,
replacement of lysine by leucine in the hydrophilic
helix region, increasing the hydrophobicity, enhanced
the hemolytic e¡ect. A strong correlation between
hemolysis and the RP-HPLC retention times, and
hence hydrophobicity, was also found for analogues
of the frog peptide brevinin 1E [59].
It should be emphasized that the results summar-
ized above are generally derived from a comparison
of peptides which di¡er in more than one structural
parameter. For example, replacement of a lysine res-
idue for leucine in the hydrophobic helix face [51] not
only reduces the hydrophobicity, but also modi¢es
amphipathicity and overall charge (see also Sections
2.1, 2.2 and 2.5). Deletion of N-terminal residues
from brevinin 1E a¡ects not only its hydrophobicity
but also its helix propensity and the hydrophobic
moment [59]. Such simultaneous alteration of more
than one structural parameter complicates assess-
ment of the role of hydrophobicity and may be one
reason for the contradictory results obtained for the
relation between hydrophobicity and antibacterial ef-
fect.
In order to address this problem, we have designed
peptide analogues with varied hydrophobicity but
with other structural parameters largely unchanged.
Hydrophobicity-modi¢ed analogues were derived
from the amino acid sequence of the bacteria-selec-
tive magainin 2 amide and the amphipathic helical
model peptide KLAL, which exhibits high antibacte-
rial as well as hemolytic activity [33,53,60]. In agree-
ment with the work discussed above, a strong corre-
lation between hydrophobicity and the hemolytic
e¡ect was evident in both peptide sets. Likewise,
the antibacterial activity against E. coli, Pseudomonas
aeruginosa and Staphylococcus aureus was found to
increase with increasing peptide hydrophobicity.
However, the relative in£uence of hydrophobicity
was often larger for the hemolytic than for the anti-
bacterial e¡ect. Thus, the more pronounced reduc-
tion of hemolytic activity compared to antimicrobial
activity with decreasing hydrophobicity led to a se-
lectively antimicrobial KLAL analogue. An en-
hanced antibacterial speci¢city can thus be achieved
by reducing the peptide hydrophobicity. An addi-
tional consequence of this ¢nding is that a hydro-
phobicity-based gain in antibacterial activity is likely
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accompanied by a reduced antibacterial speci¢city.
Such a reduced antibacterial speci¢city with increas-
ing peptide hydrophobicity was also observed for
PGLa analogues [61].
The molecular basis for the larger in£uence of hy-
drophobicity on the hemolytic than on the antibac-
terial e¡ect was investigated using model membranes
[33,60]. Hydrophobicity modi¢cations led to large
di¡erences in the potential of peptides to permeabi-
lize electrically neutral phosphatidylcholine mem-
branes. However, the di¡erences between analogues
of varied hydrophobicity considerably decreased with
increasing content of negatively charged lipids in the
model membrane. Obviously, the electrostatic accu-
mulation of basic peptides in the vicinity of the neg-
atively charged membrane reduces the relative con-
tribution of hydrophobicity to the overall e¡ect.
Another important question is to clarify whether
hydrophobicity-induced activity modi¢cations arise
exclusively from changes in the lipid a⁄nity or also
from di¡erences in the membrane-disturbing activity
of the bound peptide. For the magainin hydropho-
bicity set, the analysis of binding isotherms and ac-
tivity pro¢les determined for moderately negatively
charged lipid bilayers revealed that hydrophobicity
mainly modulated the lipid a⁄nity (Fig. 3) [60]. An
in£uence on the membrane-disturbing activity of the
bound peptide was found for the interaction of hy-
drophobicity modi¢ed KLAL peptides with neutral
phosphatidylcholine bilayers (Dathe, unpublished re-
sults). On highly negatively charged membranes,
modi¢cation of hydrophobicity of the cationic pep-
tides is without any relevance.
2.4. Angle subtended by the hydrophilic/hydrophobic
helix surfaces
Membrane binding involves penetration of the
peptide’s hydrophobic helix face into the lipid acyl
chain region, whereas the hydrophilic peptide groups
remain in contact with the polar lipid head groups
and the aqueous surroundings. Membrane binding
and perturbation are hence expected to depend on
the relative size of the hydrophilic and hydrophobic
helix cores. A simple parameter used to express the
hydrophilic/hydrophobic residue distribution within
an amphipathic helical peptide is the angle subtended
by the hydrophobic or hydrophilic helix face. Inde-
pendent of the hydrophobicity and the hydrophobic
moment, the hydrophobic/hydrophilic angle is ex-
pected to in£uence the location of the peptide within
the membrane and the structure of the transmembra-
nal pores. Furthermore, the distribution of polar and
non-polar residues may induce a positive or negative
membrane curvature strain, thereby destabilizing lip-
id bilayer membranes.
A simple classi¢cation of the membrane location
of membrane-binding peptides with regard to their
hydrophobic/hydrophilic domain size was suggested
by Brasseur et al. [62]. According to their classi¢ca-
tion, peptides with a small hydrophilic angle and a
high overall hydrophobicity associate to form trans-
membranal pores, whereas peptides with approxi-
mately equivalent hydrophilic and hydrophobic cores
orient parallel to the membrane surface. The cur-
rently available experimental data for native antibac-
terial peptides suggest that these are predominantly
located parallel to the membrane surface, independ-
ent of their hydrophilic/hydrophobic angle [44,63^
65]. However, these ¢ndings do not exclude the pos-
sibility that a minor fraction of the bound peptide is
involved in the formation of transmembranal pores.
Kiyota et al. [66] investigated 18-residue amphi-
pathic model peptides with rather drastically varied
hydrophobic/hydrophilic domain sizes. The peptides
consisted solely of lysine and leucine in a ratio vary-
ing between 5:13 and 13:5. The ability of the ana-
logues to induce lipid vesicle leakage and hemolysis
completely paralleled the magnitude of the hydro-
phobic area. A deep penetration into the hydropho-
bic bilayer core was observed for peptides containing
at least nine leucine residues. Peptides with less leu-
cine residues were only able to interact with nega-
tively charged membranes. Obviously, a broad hy-
drophobic core is a prerequisite for e¡ective
hydrophobic membrane perturbation. It should be
mentioned that these results can also be interpreted
on the basis of a modi¢ed peptide hydrophobicity
and charge. Speci¢c conclusions concerning the role
of the polar/non-polar angle cannot be drawn.
An attempt to understand the in£uence of the an-
gle subtended by the polar/non-polar helix face was
made by Tytler et al. [67]. According to the classi¢-
cation of Segrest et al. [68], many antibacterial K-
helical peptides belong to the class L (lytic) amphi-
pathic peptides, characterized by a high mean residue
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hydrophobic moment and a narrow hydrophilic helix
face containing predominantly lysine residues, whose
long side chains can allow increased penetration of
the peptide into the membrane. The inverted wedge
shape of class L peptides leads to the induction of a
negative curvature strain and the resulting bilayer-
destabilizing e¡ect has been suggested to be the mo-
lecular basis of membrane permeabilization [67,69].
In addition, the potential of a peptide to induce a
negative curvature strain facilitates membrane fu-
sion, thereby providing an alternative mechanism of
membrane permeabilization [70]. The apex angle of
the inverted wedge is mainly determined by the an-
gles circumscribed by the hydrophilic and hydropho-
bic helix regions and the hydrophilic/hydrophobic
domain sizes should hence have a marked in£uence
on the peptide potential to induce curvature strain.
In order to test this hypothesis, Tytler et al. [67]
investigated three peptides derived from the model
peptide 18L with polar face angle of 100‡, 120‡,
and 140‡, respectively, and reported a decrease in
the hemolytic activity with increasing angle. Di¡er-
ential scanning calorimetry experiments revealed that
18L promotes the formation of the inverted hexago-
nal phase (HII) of phosphatidylethanolamine and in-
duces a negative curvature strain. The decreased he-
molytic e¡ect with increasing polar angle (comprised
mainly by positively charged lysine residues) was
hence explained by the reduced e¡ectiveness in in-
ducing negative curvature strain. It should be men-
tioned that the analogues with increased polar angle
also possessed a reduced hydrophobic moment.
Therefore, the decreased hemolytic e¡ect may at least
partially arise from the reduced amphipathicity.
Membrane destabilization can generally also be
induced by a positive curvature strain. In fact, in
contradiction to the expectation for class L peptides,
recent investigations of the antibacterial peptides
magainin 2 amide (120‡ polar angle) [71], PGLa
(80‡ polar angle) and the model peptide KLAL
(80‡ polar angle) (Wieprecht and Dathe, unpublished
results) have shown that these peptides raise the bi-
layer-to-hexagonal phase transition temperature of a
phosphatidylethanolamine membrane and are hence
able to induce a positive curvature strain in a strain-
free membrane. In order to investigate systematically
the in£uence of the polar/non-polar helical angles on
the membrane perturbation activity, we have de-
signed peptide sets in which the polar/positively
charged angle of magainin and KLAL was varied
between 80‡ and 180‡. In accordance with our design
principles, the hydrophobicity, the hydrophobic mo-
ment and the number of charged residues were main-
tained constant within each peptide set. Di¡erential
scanning calorimetry revealed that all analogues, in-
dependent of their polar angle, raised the bilayer-to-
hexagonal phase transition temperature of phospha-
tidylethanolamine and hence induced positive curva-
ture strain [71] (Wieprecht and Dathe, unpublished
results). For the magainin set, the activity to permea-
bilize model membranes, the antibacterial activity as
well as the hemolytic activity were enhanced in those
analogues with a large positively charged domain.
The enhanced activity of these analogues was traced
back to an increased lipid a⁄nity (Fig. 3). However,
the membrane-disturbing e⁄ciency of the membrane-
bound peptide decreased with increasing angle sub-
tended by the positively charged helix face. This ¢nd-
ing is in accordance with a pore formation model
recently suggested for magainin [72]. The mem-
brane-permeabilizing e⁄ciency of analogues with en-
hanced angle of positively charged residues is re-
duced due to electrostatic repulsion between
adjacent helices within the pore, thus resulting in a
decreased pore-forming probability and/or pore de-
stabilization. Recently, Matsuzaki et al. [73] sug-
gested that the potential of magainin to induce pos-
itive curvature strain might even facilitate the
formation of a torus-type pore.
In contrast to the results obtained for the magai-
nins, modulation of the size of the hydrophobic/hy-
drophilic domains of the more hydrophobic KLAL
model peptides had only a slight in£uence on their
antimicrobial and hemolytic activities [53]. The mod-
erate activity changes on red blood cells correlated
with a low in£uence of the size of the charged/hydro-
phobic domain on the permeabilizing activity on
neutral lipid bilayers. This highlights the dominance
of the intrinsic hydrophobicity of the KLAL peptides
and shows that the modulating potential of the size
of the polar/hydrophobic domains is generally con-
nected with the magnitude of other structural param-
eters. The ability of the KLAL and magainin pep-
tides to induce dye release from highly negatively
charged phosphatidylglycerol vesicles decreased
with increasing polar angle [54]. Since di¡erences in
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the membrane a⁄nity of the analogues are negligible
at highly negatively charged membranes, it is evident
that changes of the balance between the polar and
hydrophobic domain of this type of peptides mainly
a¡ect the permeabilizing e⁄ciency.
2.5. Charge
Most natural antibacterial and hemolytic peptide
are positively charged. The speci¢c role of a positive
peptide charge for the interaction with the negatively
charged membranes of Gram-positive and Gram-
negative bacteria has long been recognized and is
documented by a variety of attempts to induce or
to improve antimicrobial activity by charge modi¢-
cation. The electrically neutral N-hemolysin (Table 1)
is highly hemolytic but devoid of antimicrobial activ-
ity. Introduction of a cationic net charge by substi-
tution of negatively charged residues by lysine con-
ferred upon the peptide potent antibacterial activity
[74]. The addition of ten lysine residues to the N-
terminus of the antibacterial magainin 2 drastically
increased antibacterial activity without enhancing he-
molytic activity [75]. Also, glutamic acid exchange by
alanine [76] or glutamine [77] enhanced the positive
charge of magainin and increased antimicrobial po-
tency. Conversely, a gradual reduction of the positive
peptide charge resulted in a loss of antimicrobial
activity, while the hemolytic activity was less in£u-
enced or even increased as shown for magainin [77]
and the N-terminal stretch of pardaxin [26].
There is, however, no simple correlation between
peptide charge and antimicrobial activity. In model
peptides composed solely of leucine and lysine resi-
dues, enhancement as well as reduction of charge led
to analogues with increased antibacterial activity
[51]. We again emphasize that these substitutions
also modify other peptide structural parameters.
Other studies of synthetic model peptides [66] and
magainin analogues (Dathe et al., to be published)
showed that highly cationic peptides might even be
devoid of antibacterial activity though they are
highly hemolytic.
Our studies of the role of amphipathicity and hy-
drophobicity in the antimicrobial and hemolytic ac-
tion of helical peptides led to the suggestion that
peptide-membrane interactions are determined by a
sensitive balance of electrostatic and hydrophobic
interactions [53]. Reinforcement of electrostatic inter-
actions by modi¢cation of the positive peptide
charge, together with a conservation of a high per-
meabilizing e⁄ciency based on a well developed hy-
drophobic helix domain, is expected to enhance the
antibacterial activity and to improve prokaryotic se-
lectivity. Following the strategy of systematic varia-
tion of one parameter while conserving all others, we
studied magainin analogues of modi¢ed charge
(Dathe, to be published). As expected, the increase
of peptide charge enhanced the activity against
Gram-positive as well as Gram-negative bacteria. Si-
multaneously, the hemolytic activity practically dis-
appeared. Compared to the native magainin 2 amide,
the antimicrobial activity of the most potent ana-
logue was increased by a factor of about 50, and
the selectivity for E. coli could be substantially im-
proved. However, extension of the cationic charge
beyond a threshold reduced the bactericidal activity
and very high hemolytic activity resulted in a loss of
prokaryotic speci¢city.
To elucidate the basic principles underlying the
membrane permeabilizing process, it is important
to know how peptide charge modulates membrane
a⁄nity and the permeabilizing e⁄ciency of peptides.
The role of electrostatic interactions in the binding
step is well established. Titration calorimetry studies
showed that binding can be treated as a simple par-
tition of peptide molecules between the aqueous
phase and the membrane surface, provided that the
e¡ect of electrostatic attraction to or repulsion from
the membrane surface is properly corrected (for a
review, see [78]). Using the Gouy-Chapman theory
to correct for electrostatic e¡ects, it was recently
shown that the enhanced lipid a⁄nity of magainin
for negatively charged membranes is a consequence
of the increased peptide concentration in the vicinity
of the membrane due to the negative surface poten-
tial. A speci¢c interaction of the positively charged
peptide with the negatively charged membrane could
be excluded [79,80]. Increasing a⁄nity in connection
with enhanced negative charge density of lipid bi-
layers was also reported for melittin [81], cecropin
B [82], cecropin P1 [29] or magainin [32,83]. Further
insight into the role of electrostatic interactions
comes from studies with de novo designed com-
pounds [84]. Cationic peptides containing a sequence
region composed exclusively of hydrophobic residues
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spontaneously inserted into negatively charged as
well as neutral phospholipid bilayers. However, the
introduction of less hydrophobic residues into the
hydrophobic block resulted in analogues possessing
selectivity for negatively charge membranes. This
underlines the importance of electrostatic interac-
tions between the lipid head groups and basic resi-
dues of the peptide for the membrane binding of
peptides lacking a purely hydrophobic chain region.
This principle is also well documented in native pep-
tides, as a comparison of melittin and magainin re-
veals (Fig. 1, Table 1). Melittin, characterized by a
very hydrophobic N-terminus and an extremely po-
lar, charged C-terminus, interacts with neutral as
well as negatively charged lipid bilayers and lyses
red blood cells and bacterial membranes. In contrast,
magainin, which lacks a hydrophobic chain segment,
preferentially interacts with negatively charged lipid
bilayers and possesses antibacterial speci¢city.
Electrostatic peptide-membrane lipid interactions
are also an important determinant of the permeabi-
lizing e⁄ciency of peptides. Inhibition of the lytic
potential with increasing negative membrane charge
has been reported for a KLAL model peptide and
magainin 2 amide [33,60]. The reduction of the per-
meabilizing e⁄ciency (Fig. 2) has been proposed to
result from strong electrostatic peptide-lipid interac-
tions which anchor the cationic peptide in the lipid
head group region. Inhibited membrane immersion
has also been suggested to be responsible for the
reduced lytic activity of melittin against highly neg-
atively charged lipid bilayers [85]. Competing e¡ects
are also operative when the cationic charge of mag-
ainin is enhanced [77]. An increased charge improved
peptide binding to the negatively charged lipid mem-
brane, but intermolecular repulsion between highly
cationic peptide helices within the pore structure dis-
turbed the permeabilizing mechanism and thus re-
duced lytic activity.
The studies above emphasize the importance of
cationic peptide charge for the recognition of bacte-
rial membranes. However, because of the sensitive
balance of electrostatic and hydrophobic peptide-
membrane interactions, a simple correlation between
the number and position of cationic residues on the
one hand and activity and antimicrobial speci¢city
on the other hand does not exist.
3. Summary: the potential of global structural
parameters to modulate activity
In recent years, our knowledge concerning the role
of structural motifs in antimicrobial peptides for
membrane activity and selectivity has been signi¢-
cantly increased.
Studies of a variety of natural peptides and their
chemically modi¢ed analogues, as well as model
compounds, convincingly demonstrated that a cati-
onic charge is essential for the antimicrobial e¡ect.
Since electrostatic interactions are advantageous for
binding but tend to decrease the ability of peptides to
permeabilize negatively charged membranes, the im-
portance of charge for the antimicrobial e¡ect con-
sists in (i) recognition of the bacterial membrane and
(ii) high peptide accumulation in the vicinity of the
target membrane. To possess antimicrobial activity,
less hydrophobic peptides should have a well devel-
oped hydrophobic domain providing the peptide
with a high hydrophobic moment, while peptides
with low amphipathicity may display antimicrobial
activity if they possess an appropriate high intrinsic
hydrophobicity.
The concentration of natural antimicrobial pep-
tides necessary to inhibit bacterial growth is usually
in the micromolar range. All studies published so far
indicate that the opportunities to distinctly increase
activity by modi¢cation of structural motifs are lim-
ited. The growth-inhibiting concentration of most
e¡ective peptide analogues has been found to be
only slightly below 1 WM.
The importance of the peptide structural parame-
ters charge, helicity, hydrophobic moment, hydro-
phobicity and domain size (Table 2) consists in their
di¡erent roles in the interaction with the membranes
of prokaryotic and eukaryotic cells.
With reduction of electrostatic interactions due to
a decreased membrane charge, the activity-modulat-
ing potential of hydrophobicity, the hydrophobic
moment and the size of the hydrophobic domain
becomes more pronounced (Table 2). The e¡ective
disturbance of the electrically neutral membrane is
more dependent on a high permeabilizing e⁄ciency
than on a high lipid a⁄nity. Since the hemolytic
activity can be e¡ectively reduced through reduction
of amphipathicity (helix disturbance, reduction of the
hydrophobic moment), lowering the size of the hy-
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drophobic domain and decreasing the intrinsic hy-
drophobicity, these variables provide a powerful ba-
sis for the improvement of the antimicrobial selectiv-
ity.
The results summarized in this review are in ac-
cordance with a model of peptide-lipid interactions
which explains the di¡erent activities by changes in
the membrane a⁄nity and in the location of bound
peptides. On negatively charged membranes electro-
static interactions cause a high peptide accumulation
and a tight binding of the peptide molecules to the
lipid head groups. This surface state is less e¡ective
for permeabilization. On neutral membranes, hydro-
phobic interactions become signi¢cant, and despite
low binding a⁄nities, the peptides may penetrate
deeply into the hydrophobic membrane region and
thereby e¡ectively disturb the barrier function of the
lipid bilayer.
This mechanistic picture of di¡erences in the dom-
inance of electrostatic and hydrophobic peptide-
membrane lipid interactions provides an explanation
for the di¡erent activity spectra (Table 1) of peptides
such as the hemolytic N-hemolysin, the hemolytic and
antibacterial melittin and the antibacterial magainin
and cecropin P1, which is selective for Gram-nega-
tive bacteria.
N-Hemolysin is inactive against bacteria, since a
net charge of zero prevents peptide accumulation at
negatively charged bacterial membranes. However,
the high hydrophobic moment of the well developed
amphipathic helix allows binding to and penetration
into the neutral membranes of erythrocytes.
The activity of melittin on eukaryotic cell mem-
branes is mediated by strong hydrophobic interac-
tions between the extensive hydrophobic N-terminal
peptide domain and the neutral membrane (Fig. 1).
The large angle of the N-terminal hydrophobic helix
domain and the low charge of its small polar coat
support a deep penetration into the hydrophobic
membrane interior and might favor the association
of membrane-bound peptides to form transmem-
brane ion channels. The e¡ect on prokaryotic mem-
branes is additionally favored by ionic interactions of
the charged C-terminus, causing peptide accumula-
tion in the outer lea£et of negatively charged mem-
branes.
In magainin, structural motifs favoring hydropho-
bic interactions are poorly developed: the cationic
charge is spread over the whole peptide chain and
the hydrophobicity and hydrophobic moment are
only moderate (Fig. 1). Hence, magainins are not
hemolytic. However, electrostatic contributions to
membrane interactions result in antimicrobial activ-
ity against Gram-positive bacteria. The activity
against Gram-negative bacteria is even higher be-
cause of additional pronounced accumulation at the
outer wall. The large, mildly hydrophobic domain
allows shallow insertion of the helical rod parallel
to the membrane surface. Reorientation of magainin
helices making the outer and inner lea£ets a contin-
uum while keeping the charged peptide face always
in contact with the lipid head groups may lead to
complex transbilayer pores.
A high cationic charge, low hydrophobicity, low
hydrophobic moment and a small hydrophobic do-
main prevent interaction of cecropin P1 (Fig. 1) with
the neutral membrane of erythrocytes. However,
electrostatic forces mediate high activity of cecropin
P1 against bacteria. The e¡ect of the poorly devel-
oped hydrophobic domain which seems to inhibit
peptide penetration into the hydrophobic membrane
region of Gram-positive bacteria is partially compen-
sated by a pronounced accumulation on the envelope
of Gram-negative bacteria to give high activity. It is
reasonable to assume that the peptide accumulation
in the outer lea£et of the negatively charged target
membrane enhances the interfacial tension disturbing
the bilayer packing and ¢nally leading to membrane
disruption.
In summary, the structural parameters of mem-
brane-lytic peptides discussed in this review are e¡ec-
tive modulators of membrane activity. Provided the
properties of the target membrane are known, the
balance between hemolytic and antimicrobial activity
can be optimized by variation of the individual pa-
rameters. However, general optimization of activity
against a broad spectrum of pathogens is a multi-
dimensional problem and has proved di⁄cult to
solve. Each peptide has its unique spectrum of activ-
ity determined by the combination of the structural
motifs discussed. Furthermore, the di¡erences in lip-
id composition and the architecture of the mem-
branes of di¡erent target cells complicate activity
optimization. Finally, recent reports concerning the
translocation of amphipathic peptides through cell
membranes [86] and peptide binding to DNA [87]
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lead to speculations that the mechanism of action
could be more complex than originally anticipated
and might involve also events others than the break-
down of the membrane barrier function.
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